Alan Stewart Penzias, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 52 | 2024 | 1284 | 4.780 |
Why?
|
| Infertility | 26 | 2023 | 655 | 3.310 |
Why?
|
| Preimplantation Diagnosis | 12 | 2023 | 151 | 3.290 |
Why?
|
| Embryo Transfer | 25 | 2023 | 510 | 2.920 |
Why?
|
| Blastocyst | 10 | 2023 | 424 | 2.200 |
Why?
|
| Live Birth | 21 | 2024 | 512 | 2.000 |
Why?
|
| Pregnancy Rate | 25 | 2024 | 643 | 1.430 |
Why?
|
| Reproductive Techniques, Assisted | 7 | 2023 | 482 | 1.300 |
Why?
|
| Embryo Implantation | 8 | 2021 | 272 | 1.190 |
Why?
|
| Birth Rate | 13 | 2024 | 170 | 1.110 |
Why?
|
| Ploidies | 4 | 2024 | 281 | 1.070 |
Why?
|
| Ovulation Induction | 10 | 2024 | 274 | 1.010 |
Why?
|
| Aneuploidy | 10 | 2024 | 530 | 0.860 |
Why?
|
| Reproductive Medicine | 2 | 2022 | 108 | 0.840 |
Why?
|
| Fertility | 10 | 2023 | 781 | 0.800 |
Why?
|
| Maternal Age | 6 | 2017 | 802 | 0.790 |
Why?
|
| Pregnancy Outcome | 10 | 2020 | 2795 | 0.770 |
Why?
|
| Pregnancy | 67 | 2024 | 29144 | 0.760 |
Why?
|
| Abortion, Spontaneous | 3 | 2023 | 544 | 0.730 |
Why?
|
| Embryonic Development | 4 | 2019 | 711 | 0.690 |
Why?
|
| Progesterone | 9 | 2023 | 776 | 0.690 |
Why?
|
| Philosophy, Medical | 1 | 2018 | 79 | 0.630 |
Why?
|
| Infertility, Female | 8 | 2018 | 787 | 0.590 |
Why?
|
| Multiple Birth Offspring | 3 | 2012 | 21 | 0.580 |
Why?
|
| Religion and Medicine | 1 | 2018 | 163 | 0.570 |
Why?
|
| Luteal Phase | 4 | 2003 | 147 | 0.540 |
Why?
|
| Family Planning Services | 1 | 2018 | 263 | 0.520 |
Why?
|
| Cryopreservation | 6 | 2024 | 670 | 0.520 |
Why?
|
| Oocytes | 15 | 2024 | 1187 | 0.510 |
Why?
|
| Embryo Culture Techniques | 2 | 2016 | 80 | 0.490 |
Why?
|
| Ovarian Follicle | 6 | 2010 | 247 | 0.480 |
Why?
|
| Insurance Coverage | 3 | 2023 | 1901 | 0.460 |
Why?
|
| Ovary | 6 | 2018 | 981 | 0.430 |
Why?
|
| Abortion, Induced | 1 | 2018 | 458 | 0.420 |
Why?
|
| Genetic Testing | 8 | 2023 | 3444 | 0.420 |
Why?
|
| Follicular Fluid | 7 | 2010 | 87 | 0.410 |
Why?
|
| Oocyte Retrieval | 3 | 2024 | 161 | 0.380 |
Why?
|
| Sex Preselection | 1 | 2010 | 18 | 0.380 |
Why?
|
| Surrogate Mothers | 1 | 2010 | 17 | 0.360 |
Why?
|
| Clomiphene | 2 | 2008 | 72 | 0.340 |
Why?
|
| Gonadotropin-Releasing Hormone | 6 | 2004 | 1205 | 0.340 |
Why?
|
| Societies, Medical | 2 | 2020 | 3743 | 0.330 |
Why?
|
| Twinning, Monozygotic | 2 | 2020 | 17 | 0.330 |
Why?
|
| Osteochondrodysplasias | 1 | 2010 | 183 | 0.320 |
Why?
|
| Fallopian Tubes | 3 | 1996 | 182 | 0.320 |
Why?
|
| Female | 100 | 2024 | 380194 | 0.320 |
Why?
|
| Pregnancy, Multiple | 6 | 2016 | 217 | 0.320 |
Why?
|
| Marfan Syndrome | 1 | 2010 | 240 | 0.310 |
Why?
|
| Fertility Agents, Female | 1 | 2008 | 99 | 0.300 |
Why?
|
| Gamete Intrafallopian Transfer | 3 | 1991 | 27 | 0.300 |
Why?
|
| Leuprolide | 4 | 1994 | 321 | 0.300 |
Why?
|
| Steroids | 1 | 2012 | 930 | 0.300 |
Why?
|
| Insemination, Artificial | 1 | 2008 | 98 | 0.300 |
Why?
|
| Pregnancy, Ectopic | 3 | 1994 | 141 | 0.300 |
Why?
|
| Flavin-Adenine Dinucleotide | 2 | 2024 | 29 | 0.300 |
Why?
|
| Nafarelin | 4 | 1994 | 27 | 0.290 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2023 | 370 | 0.290 |
Why?
|
| Chorionic Gonadotropin | 7 | 2017 | 477 | 0.280 |
Why?
|
| Education, Medical | 1 | 2018 | 1721 | 0.280 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 457 | 0.270 |
Why?
|
| Embryo, Mammalian | 4 | 2019 | 1701 | 0.270 |
Why?
|
| Retrospective Studies | 37 | 2024 | 77449 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
| Endometrium | 4 | 2021 | 424 | 0.260 |
Why?
|
| Humans | 101 | 2024 | 744343 | 0.230 |
Why?
|
| NAD | 2 | 2024 | 593 | 0.220 |
Why?
|
| Infertility, Male | 3 | 2021 | 409 | 0.220 |
Why?
|
| Granulosa Cells | 6 | 2010 | 120 | 0.220 |
Why?
|
| Adult | 54 | 2024 | 214055 | 0.210 |
Why?
|
| Spermatozoa | 4 | 2021 | 625 | 0.210 |
Why?
|
| Laparoscopy | 3 | 2005 | 2151 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5442 | 0.200 |
Why?
|
| Sperm Injections, Intracytoplasmic | 5 | 2023 | 160 | 0.200 |
Why?
|
| Estradiol | 9 | 2017 | 2020 | 0.200 |
Why?
|
| Reproductive Rights | 1 | 2020 | 35 | 0.190 |
Why?
|
| Patient Dropouts | 2 | 2018 | 421 | 0.190 |
Why?
|
| Mosaicism | 1 | 2023 | 441 | 0.190 |
Why?
|
| Embryology | 1 | 2020 | 29 | 0.180 |
Why?
|
| Vitrification | 1 | 2020 | 56 | 0.180 |
Why?
|
| Fertilization | 3 | 2009 | 196 | 0.180 |
Why?
|
| Menotropins | 4 | 1994 | 45 | 0.170 |
Why?
|
| Cell Shape | 1 | 2020 | 375 | 0.170 |
Why?
|
| Reproduction | 2 | 2022 | 668 | 0.170 |
Why?
|
| Models, Statistical | 2 | 2013 | 5102 | 0.160 |
Why?
|
| Birth Weight | 4 | 2022 | 2069 | 0.150 |
Why?
|
| Follicular Phase | 3 | 2010 | 153 | 0.140 |
Why?
|
| Fallopian Tube Diseases | 1 | 1996 | 62 | 0.140 |
Why?
|
| Luteinizing Hormone | 2 | 1995 | 869 | 0.130 |
Why?
|
| Treatment Outcome | 21 | 2021 | 63114 | 0.130 |
Why?
|
| Ovarian Cysts | 2 | 1994 | 115 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2019 | 600 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2021 | 2634 | 0.130 |
Why?
|
| Boston | 5 | 2021 | 9313 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7181 | 0.120 |
Why?
|
| Cohort Studies | 9 | 2024 | 40561 | 0.120 |
Why?
|
| United States | 9 | 2023 | 69872 | 0.120 |
Why?
|
| Propensity Score | 1 | 2021 | 1781 | 0.120 |
Why?
|
| Treatment Failure | 4 | 2012 | 2618 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2023 | 694 | 0.120 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1995 | 213 | 0.120 |
Why?
|
| Pandemics | 4 | 2023 | 8388 | 0.120 |
Why?
|
| Europe | 1 | 2020 | 3339 | 0.110 |
Why?
|
| Colonic Pouches | 1 | 2014 | 121 | 0.110 |
Why?
|
| Uterus | 2 | 2012 | 711 | 0.110 |
Why?
|
| Male | 26 | 2023 | 350118 | 0.110 |
Why?
|
| Ovarian Diseases | 1 | 1994 | 139 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2020 | 1403 | 0.110 |
Why?
|
| Colitis, Ulcerative | 2 | 2016 | 1912 | 0.110 |
Why?
|
| Premature Birth | 2 | 2022 | 1721 | 0.110 |
Why?
|
| Ovulation | 2 | 1999 | 189 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2017 | 775 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 1 | 1993 | 438 | 0.110 |
Why?
|
| Growth Hormone | 1 | 1995 | 705 | 0.110 |
Why?
|
| Administration, Intravaginal | 2 | 2003 | 150 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2022 | 25625 | 0.100 |
Why?
|
| Family Characteristics | 1 | 2016 | 1000 | 0.100 |
Why?
|
| Stillbirth | 1 | 2014 | 346 | 0.100 |
Why?
|
| Young Adult | 9 | 2021 | 56430 | 0.100 |
Why?
|
| Pituitary Gland | 1 | 1994 | 665 | 0.100 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 378 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.100 |
Why?
|
| Ovariectomy | 1 | 1993 | 661 | 0.100 |
Why?
|
| Mineralocorticoids | 1 | 2010 | 38 | 0.090 |
Why?
|
| Individuality | 1 | 2012 | 307 | 0.090 |
Why?
|
| Paresthesia | 1 | 1991 | 161 | 0.090 |
Why?
|
| Probability | 2 | 2013 | 2505 | 0.090 |
Why?
|
| Collagen Type II | 1 | 2010 | 151 | 0.090 |
Why?
|
| Thrombophilia | 1 | 2012 | 305 | 0.090 |
Why?
|
| Vitamin K Deficiency | 1 | 1988 | 24 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2010 | 772 | 0.080 |
Why?
|
| Thyroid Diseases | 1 | 2012 | 379 | 0.080 |
Why?
|
| Oogenesis | 1 | 2009 | 131 | 0.080 |
Why?
|
| Twins | 1 | 2010 | 339 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2016 | 744 | 0.080 |
Why?
|
| Reproductive Techniques | 2 | 2000 | 42 | 0.080 |
Why?
|
| Methotrexate | 1 | 1994 | 1727 | 0.080 |
Why?
|
| Counseling | 1 | 2015 | 1523 | 0.080 |
Why?
|
| Bile Acids and Salts | 1 | 2009 | 367 | 0.070 |
Why?
|
| Physicians | 2 | 2022 | 4567 | 0.070 |
Why?
|
| Age Factors | 5 | 2016 | 18370 | 0.070 |
Why?
|
| Chromosomes, Human, Y | 1 | 2008 | 148 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 552 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2010 | 880 | 0.070 |
Why?
|
| Neck | 1 | 1991 | 697 | 0.070 |
Why?
|
| Zona Pellucida | 2 | 1996 | 18 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9438 | 0.070 |
Why?
|
| Forecasting | 2 | 2012 | 2951 | 0.070 |
Why?
|
| Apolipoproteins | 1 | 2009 | 317 | 0.070 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1988 | 183 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 296 | 0.070 |
Why?
|
| Leiomyoma | 1 | 2012 | 730 | 0.070 |
Why?
|
| Biopsy | 4 | 2020 | 6756 | 0.070 |
Why?
|
| Vitamin K | 1 | 1988 | 295 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2009 | 690 | 0.070 |
Why?
|
| Risk Factors | 8 | 2021 | 72290 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 29063 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2010 | 759 | 0.070 |
Why?
|
| Blood Coagulation Disorders | 1 | 1988 | 337 | 0.060 |
Why?
|
| Cholestasis | 1 | 1988 | 378 | 0.060 |
Why?
|
| Face | 1 | 1991 | 994 | 0.060 |
Why?
|
| Students, Medical | 1 | 2018 | 1862 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3605 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2020 | 4245 | 0.060 |
Why?
|
| Decision Making | 1 | 2019 | 3887 | 0.060 |
Why?
|
| Prospective Studies | 8 | 2022 | 53288 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 1152 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2016 | 9849 | 0.060 |
Why?
|
| Aging | 5 | 2009 | 8664 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2016 | 2425 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5137 | 0.060 |
Why?
|
| Gonadotropins | 1 | 2004 | 241 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2016 | 2303 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 1956 | 0.050 |
Why?
|
| Corpus Luteum | 2 | 1993 | 86 | 0.050 |
Why?
|
| Single Embryo Transfer | 1 | 2022 | 29 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 1513 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2018 | 4687 | 0.050 |
Why?
|
| Birth Intervals | 1 | 2022 | 51 | 0.050 |
Why?
|
| Gestational Age | 3 | 2021 | 3493 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3188 | 0.050 |
Why?
|
| Gels | 1 | 2003 | 427 | 0.050 |
Why?
|
| Time Factors | 7 | 2021 | 40075 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2017 | 5985 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 1831 | 0.050 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 1813 | 0.050 |
Why?
|
| Semen | 1 | 2023 | 316 | 0.050 |
Why?
|
| Cholesterol | 1 | 2009 | 2917 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2016 | 12720 | 0.050 |
Why?
|
| Obesity | 3 | 2024 | 12745 | 0.050 |
Why?
|
| Cell Count | 3 | 1993 | 1856 | 0.050 |
Why?
|
| Mandatory Programs | 1 | 2020 | 87 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2008 | 3913 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2001 | 410 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2022 | 424 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2024 | 8324 | 0.040 |
Why?
|
| Demography | 1 | 2004 | 1656 | 0.040 |
Why?
|
| Oocyte Donation | 1 | 1999 | 49 | 0.040 |
Why?
|
| Empathy | 1 | 2023 | 474 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2021 | 440 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6538 | 0.040 |
Why?
|
| Mucins | 1 | 2001 | 564 | 0.040 |
Why?
|
| Oxygen | 1 | 2009 | 4189 | 0.040 |
Why?
|
| Micromanipulation | 1 | 1997 | 53 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 850 | 0.040 |
Why?
|
| Karyotyping | 1 | 2019 | 1243 | 0.040 |
Why?
|
| Public Policy | 1 | 2022 | 572 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 3507 | 0.040 |
Why?
|
| Patients | 1 | 2004 | 900 | 0.040 |
Why?
|
| ROC Curve | 2 | 2016 | 3527 | 0.040 |
Why?
|
| Prevalence | 2 | 2012 | 15226 | 0.040 |
Why?
|
| Adolescent | 5 | 2020 | 85781 | 0.040 |
Why?
|
| Cleavage Stage, Ovum | 2 | 1993 | 44 | 0.040 |
Why?
|
| Anxiety | 2 | 2022 | 4297 | 0.040 |
Why?
|
| Microscopy | 1 | 2022 | 903 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 1738 | 0.040 |
Why?
|
| Cytoplasm | 2 | 1997 | 1539 | 0.030 |
Why?
|
| Estrus | 1 | 1995 | 81 | 0.030 |
Why?
|
| Apomorphine | 1 | 1995 | 150 | 0.030 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 1995 | 43 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 8987 | 0.030 |
Why?
|
| Liver | 2 | 2009 | 7474 | 0.030 |
Why?
|
| Levonorgestrel | 1 | 1995 | 77 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2004 | 2052 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1534 | 0.030 |
Why?
|
| Blastomeres | 1 | 1993 | 28 | 0.030 |
Why?
|
| Middle Aged | 7 | 2021 | 213383 | 0.030 |
Why?
|
| Weight Gain | 1 | 2024 | 2292 | 0.030 |
Why?
|
| Somatostatin | 1 | 1995 | 459 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 1993 | 134 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1995 | 610 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1995 | 362 | 0.030 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2014 | 189 | 0.030 |
Why?
|
| Specimen Handling | 2 | 1994 | 694 | 0.030 |
Why?
|
| Testicular Hormones | 1 | 1993 | 188 | 0.030 |
Why?
|
| Leadership | 1 | 2022 | 1357 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1654 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1998 | 582 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 326 | 0.030 |
Why?
|
| Weight Loss | 1 | 2024 | 2622 | 0.030 |
Why?
|
| Hysterosalpingography | 1 | 1992 | 30 | 0.030 |
Why?
|
| Laparoscopes | 1 | 1992 | 41 | 0.030 |
Why?
|
| Ontario | 1 | 2013 | 383 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 1995 | 415 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12245 | 0.030 |
Why?
|
| Spain | 1 | 2013 | 465 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 1993 | 385 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2021 | 2044 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.020 |
Why?
|
| Analysis of Variance | 3 | 1995 | 6365 | 0.020 |
Why?
|
| Fasting | 2 | 1995 | 1593 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 8301 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 25043 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1992 | 446 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1992 | 666 | 0.020 |
Why?
|
| Menstruation Disturbances | 1 | 1991 | 148 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2000 | 2278 | 0.020 |
Why?
|
| Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Blood Glucose | 2 | 1995 | 6256 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2012 | 475 | 0.020 |
Why?
|
| Corticosterone | 1 | 2010 | 310 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2013 | 1005 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3396 | 0.020 |
Why?
|
| alpha-Macroglobulins | 1 | 2009 | 64 | 0.020 |
Why?
|
| Laparotomy | 1 | 1991 | 473 | 0.020 |
Why?
|
| Regression Analysis | 3 | 1993 | 6459 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 21746 | 0.020 |
Why?
|
| Linear Models | 2 | 2016 | 5952 | 0.020 |
Why?
|
| Public Health | 1 | 2022 | 2603 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1992 | 968 | 0.020 |
Why?
|
| Hospital Costs | 1 | 1995 | 985 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2020 | 2494 | 0.020 |
Why?
|
| Reference Values | 1 | 1995 | 4982 | 0.020 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1990 | 255 | 0.020 |
Why?
|
| Diet, Mediterranean | 1 | 2014 | 700 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2065 | 0.020 |
Why?
|
| Culture Media | 1 | 2009 | 908 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 411 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 2866 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1993 | 3508 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2255 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15076 | 0.020 |
Why?
|
| Microinjections | 2 | 1997 | 327 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 1995 | 1373 | 0.020 |
Why?
|
| Parity | 1 | 2009 | 929 | 0.020 |
Why?
|
| Rats | 3 | 2001 | 24260 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1730 | 0.020 |
Why?
|
| Aldosterone | 1 | 2010 | 877 | 0.020 |
Why?
|
| Androgens | 1 | 1993 | 1281 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 29786 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1993 | 5974 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 23338 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 2118 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1993 | 2263 | 0.020 |
Why?
|
| Meiosis | 2 | 1996 | 339 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1992 | 1695 | 0.010 |
Why?
|
| Life Style | 1 | 2014 | 3835 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1119 | 0.010 |
Why?
|
| Insulin | 2 | 1995 | 6580 | 0.010 |
Why?
|
| Massachusetts | 2 | 2012 | 8663 | 0.010 |
Why?
|
| Diestrus | 1 | 2001 | 8 | 0.010 |
Why?
|
| Pseudopregnancy | 1 | 2001 | 11 | 0.010 |
Why?
|
| Proestrus | 1 | 2001 | 19 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3870 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13408 | 0.010 |
Why?
|
| Proteins | 2 | 1995 | 6103 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.010 |
Why?
|
| Glucose | 1 | 1993 | 4397 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2203 | 0.010 |
Why?
|
| Depression | 1 | 2020 | 7766 | 0.010 |
Why?
|
| Mifepristone | 1 | 2001 | 150 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 1993 | 3864 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
| Ascites | 1 | 2001 | 344 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 5987 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 2001 | 367 | 0.010 |
Why?
|
| Sperm Head | 1 | 1998 | 10 | 0.010 |
Why?
|
| DNA | 1 | 1992 | 7301 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15540 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2645 | 0.010 |
Why?
|
| Animals | 5 | 2001 | 168757 | 0.010 |
Why?
|
| Metaphase | 1 | 1997 | 151 | 0.010 |
Why?
|
| Cell Nucleus | 2 | 1996 | 2969 | 0.010 |
Why?
|
| Egg Proteins | 1 | 1996 | 58 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4409 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1992 | 12959 | 0.010 |
Why?
|
| Diet | 1 | 2014 | 7939 | 0.010 |
Why?
|
| Chromatin | 2 | 1998 | 2934 | 0.010 |
Why?
|
| Triplets | 1 | 1995 | 43 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23403 | 0.010 |
Why?
|
| Child | 1 | 2023 | 77709 | 0.010 |
Why?
|
| Fathers | 1 | 1997 | 358 | 0.010 |
Why?
|
| Biotin | 1 | 1995 | 254 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19905 | 0.010 |
Why?
|
| Cell Cycle | 2 | 1993 | 2967 | 0.010 |
Why?
|
| Mice | 3 | 2001 | 81183 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2001 | 1951 | 0.010 |
Why?
|
| Immunoradiometric Assay | 1 | 1993 | 24 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1995 | 405 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 6473 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 1993 | 266 | 0.010 |
Why?
|
| Intensive Care, Neonatal | 1 | 1995 | 198 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 1801 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1998 | 754 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9583 | 0.010 |
Why?
|
| Postnatal Care | 1 | 1995 | 236 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 39050 | 0.010 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 1992 | 22 | 0.010 |
Why?
|
| Hydroxyprogesterones | 1 | 1992 | 25 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1993 | 287 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1993 | 331 | 0.010 |
Why?
|
| Hormones | 1 | 1995 | 889 | 0.010 |
Why?
|
| Anti-Mullerian Hormone | 1 | 1993 | 402 | 0.010 |
Why?
|
| Testosterone | 1 | 2001 | 2420 | 0.010 |
Why?
|
| Biological Assay | 1 | 1993 | 652 | 0.010 |
Why?
|
| Nervous System Neoplasms | 1 | 1990 | 91 | 0.010 |
Why?
|
| Connecticut | 1 | 1990 | 366 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1992 | 20129 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1995 | 5179 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1998 | 1886 | 0.000 |
Why?
|
| Prenatal Care | 1 | 1995 | 1092 | 0.000 |
Why?
|
| Mothers | 1 | 1997 | 2165 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1993 | 1801 | 0.000 |
Why?
|
| Cell Division | 1 | 1993 | 4568 | 0.000 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 498 | 0.000 |
Why?
|
| Membrane Glycoproteins | 1 | 1996 | 3768 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1998 | 10252 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1999 | 12026 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1992 | 35421 | 0.000 |
Why?
|
| Calcium | 1 | 1996 | 5756 | 0.000 |
Why?
|
| Sarcoma | 1 | 1990 | 1897 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1990 | 2541 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 4838 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1990 | 5256 | 0.000 |
Why?
|
| Melanoma | 1 | 1990 | 5510 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1990 | 13102 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1990 | 20822 | 0.000 |
Why?
|